Erythromycin Injectable (iv) Generics - Manufacturers & Suppliers
Erythrocin, Erythrocin V, Erythrocin Stearate(US)
| Product/Composition:- | Erythromycin Injectable (IV) |
|---|---|
| Strength:- | 1 g/10 mL, 2 g/10 mL |
| Form:- | Injectable (IV) |
| Reference Brands:- | Erythrocin, Erythrocin V, Erythrocin Stearate(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Erythromycin IV inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing translocation and bacterial growth. It provides rapid, effective treatment for severe respiratory, skin, and soft tissue infections. Benefits include broad-spectrum action, good tissue penetration, and reliable, quick bacterial eradication when administered under medical supervision.
Erythromycin IV is approved in both the EU and US for severe bacterial infections, including respiratory and skin infections. In the EU, brands like Erythrocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for erythromycin IV, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.